The potential appointment of Todd Blanche as Attorney General in a future Trump administration has drawn sharp criticism from reproductive rights advocates, who fear it could lead to the federal government actively pursuing abortion bans through regulatory and enforcement channels. Blanche's past statements and legal work have raised alarms about a "war to ban abortion" orchestrated by the Department of Justice (DOJ) and the Food and Drug Administration (FDA), two agencies typically operating in separate spheres.
Advocates, including those from the National Abortion Federation (NAF), are concerned that abortion bans can be implemented through means other than formal legislation. These methods include the threat of investigations and prosecutions, as well as creating barriers such as requiring individuals to travel for care. This approach, they argue, allows anti-abortion politicians to effectively ban the procedure without the need for a national ban passed by Congress.
The NAF has responded by affirming abortion access throughout pregnancy and committing to oppose viability and gestational limits in abortion laws. This stance is framed as a direct opposition to what they describe as "anti-science and policing trends in reproductive health care." The organization believes that by eliminating "legal lines that beg for enforcement," they can better protect patients and providers from potential actions by a Trump-Blanche DOJ.
These concerns highlight the ongoing debate surrounding reproductive rights in the United States, particularly in the wake of the Supreme Court's decision in Dobbs v. Jackson Women's Health Organization, which overturned Roe v. Wade. The anniversary of the Dobbs decision has become a focal point for advocacy and policy positions related to abortion access.